Technical Analysis for OLK - Olink Holding AB

Grade Last Price % Change Price Change
C 24.11 0.75% 0.18
OLK closed up 0.75 percent on Monday, March 18, 2024, on 18 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction -2.90%
Narrow Range Bar Range Contraction -2.90%
Calm After Storm Range Contraction -3.44%
Narrow Range Bar Range Contraction -3.44%
Wide Bands Range Expansion -3.44%
Overbought Stochastic Strength -3.44%
Up 3 Days in a Row Strength -3.44%
Calm After Storm Range Contraction -2.86%
Narrow Range Bar Range Contraction -2.86%
Wide Bands Range Expansion -2.86%

   Recent Intraday Alerts

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Olink Holding AB Description

Olink Holding AB (publ) provides products and services for human protein biomarker discovery worldwide. Its Olink Explore product line include protein biomarker assays primarily for cardiovascular and metabolic diseases, oncology, neurology, and inflammation; Olink Target product line comprise human protein biomarkers for monitoring immune system and downstream applications in clinical trials; and Olink Focus product line consists of custom developed solutions for customers that have identified a small number of proteins of interest, or a protein signature. The company also offers Olink Signature Q100, a qPCR readout platform for proximity extension assay; Olink NPX Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of normalized protein expression (NPX) data. In addition, it provides Olink Analysis service comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. The company was founded in 2016 and is headquartered in Uppsala, Sweden.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Natural Sciences Molecular Biology Inflammation Biomarkers Data Processing Gene Expression Bioinformatics Laboratory Techniques Polymerase Chain Reaction Assay Cardiovascular And Metabolic Diseases Real Time Polymerase Chain Reaction

Is OLK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.01
52 Week Low 14.1
Average Volume 790,228
200-Day Moving Average 21.08
50-Day Moving Average 24.09
20-Day Moving Average 23.04
10-Day Moving Average 23.69
Average True Range 0.38
RSI (14) 60.16
ADX 23.12
+DI 26.65
-DI 18.28
Chandelier Exit (Long, 3 ATRs) 23.74
Chandelier Exit (Short, 3 ATRs) 22.81
Upper Bollinger Bands 24.55
Lower Bollinger Band 21.53
Percent B (%b) 0.86
BandWidth 13.07
MACD Line 0.01
MACD Signal Line -0.18
MACD Histogram 0.1964
Fundamentals Value
Market Cap 3 Billion
Num Shares 124 Million
EPS -0.15
Price-to-Earnings (P/E) Ratio -160.73
Price-to-Sales 18.95
Price-to-Book 6.42
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.56
Resistance 3 (R3) 24.51 24.31 24.49
Resistance 2 (R2) 24.31 24.20 24.34 24.46
Resistance 1 (R1) 24.21 24.12 24.26 24.26 24.43
Pivot Point 24.01 24.01 24.04 24.04 24.01
Support 1 (S1) 23.91 23.90 23.96 23.96 23.79
Support 2 (S2) 23.71 23.82 23.74 23.76
Support 3 (S3) 23.61 23.71 23.74
Support 4 (S4) 23.66